Guildford Training Sessions; T34 Ambulatory Syringe Pump, Subcutaneous Therapy and Verification of an Expected Death

Training Date: 15/03/2017

Training sessions will be held at Burrows Lea Country Manor.

The course topics include:

Morning 

Subcutaneous Cannulation Training

  • The subcutaneous route for drug and hydration therapy
  • The history of subcutaneous infusions
  • Drugs used in palliative care
  • Subcutaneous cannula insertion
  • Monitoring and managing cannula and infusions

T34™ Ambulatory Syringe Pump Training

  • Roles and responsibilities in relation to local policy for medical device management
  • How the device is to be used safely and effectively in your clinical area
  • Relate the criteria for selecting and managing the infusion device, associated disposables and accessories
  • Practical session in setting up, managing and troubleshooting the pump

Course duration: 3 hours (including refreshments break)

Afternoon

Verification of Expected Death

  • Defining what is meant by an expected death
  • Legal, ethical and professional issues on the practice of nurse verification of expected death in a community setting.
  • National guidance and local policy/procedure.
  • How to assess and verify an expected death using a self-assessment of competency tool.

Course duration: 3.5 hours (including refreshments break)

Cost: £54.00 – £120.00

Eventbrite - Guildford T34 Syringe Pump, Subcutaneous Therapy & Verification of an Expected Death

Book both the morning and afternoon sessions to receive a 10% early bird discount on the total cost of your booking or email trainme@cmemedical.co.uk to secure your place.

Our continuous professional development training is awarded with the Skills for Health Quality Mark and our T34™ Ambulatory Syringe Pump training is RCN accredited. All our courses are delivered by specialist trainers and training counts towards your learning hours and re-validation.

More articles, stories, inspiration and innovation can be sent straight to your email by registering here.